Suppr超能文献

6-硫鸟嘌呤掺入SV40 DNA的效应。

Effects of incorporation of 6-thioguanine into SV40 DNA.

作者信息

Maybaum J, Bainnson A N, Roethel W M, Ajmera S, Iwaniec L M, TerBush D R, Kroll J J

机构信息

Department of Pharmacology, Upjohn Center for Clinical Pharmacology, University of Michigan Medical School, Ann Arbor 48109.

出版信息

Mol Pharmacol. 1987 Nov;32(5):606-14.

PMID:2824979
Abstract

The antileukemic agent 6-thioguanine (TG) is thought to inhibit DNA synthesis as a result of its incorporation into DNA. In the present study we have examined the nature of this inhibition, using replication of SV40 viral DNA as a model system. Addition of TG to SV40-infected CV1P cells from 22 to 24 hr post infection causes a dose-dependent inhibition of viral DNA synthesis. This inhibition plateaus between 250 and 2500 microM TG, resulting in a maximum decrease of viral DNA synthesis of about 50%. Pulse-chase experiments showed no detectable slowing of elongation of nascent DNA chains, whereas measurement of the conversion of incorporated 3H-dThd into supercoiled viral DNA suggested that elongation might be slightly inhibited, but by no more than 20%. Since inhibition of elongation could not account for the total depression of DNA synthesis, we hypothesized that inhibition of initiation of DNA replication takes place. This hypothesis was tested by radioactively labeling newly synthesized viral DNA and then assessing the ability of these molecules to reenter the replicating pool by density labeling with bromodeoxyuridine. The fraction of TG-containing molecules able to re-initiate replication was decreased 15%, compared to control. This effect, which was dependent on the concentration of TG added to the medium, was closely correlated to the extent of TG incorporation into the viral genome. We concluded that a portion of SV40 viral DNA synthesis inhibited by TG is due to an effect on initiation, and hypothesized that this effect may be caused by the substitution of TG for guanine in critical recognition sequences at the origin of replication. We proceeded to test this hypothesis by constructing SV40 origin sequences containing TG and then measuring their ability to bind T-antigen in vitro. The necessary deoxynucleoside triphosphate, TdGTP, was obtained by chemical phosphorylation of thiodeoxyguanosine. In order to selectively place TG within the desired region, a plasmid containing the T-antigen binding sequences was linearized so as to place these sequences at one end of the molecule, and then digested briefly with exonuclease III. The excised strand was resynthesized by use of the Klenow fragment of DNA polymerase I along with various nucleotide mixtures. Although resynthesis with mixtures containing TdGTP in place of dGTP was impeded somewhat, it was possible to achieve complete resynthesis with this analog.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

抗白血病药物6-硫鸟嘌呤(TG)被认为是由于其掺入DNA而抑制DNA合成。在本研究中,我们以SV40病毒DNA的复制作为模型系统,研究了这种抑制作用的本质。在感染后22至24小时向感染SV40的CV1P细胞中添加TG会导致病毒DNA合成呈剂量依赖性抑制。这种抑制作用在250至2500微摩尔TG之间达到平稳状态,导致病毒DNA合成最大减少约50%。脉冲追踪实验表明,新生DNA链的延伸没有可检测到的减慢,而对掺入的3H-dThd转化为超螺旋病毒DNA的测量表明,延伸可能略有抑制,但不超过20%。由于延伸抑制不能解释DNA合成的总体下降,我们推测DNA复制起始受到抑制。通过对新合成的病毒DNA进行放射性标记,然后用溴脱氧尿苷进行密度标记来评估这些分子重新进入复制池的能力,对这一推测进行了检验。与对照相比,能够重新起始复制的含TG分子的比例降低了15%。这种效应取决于添加到培养基中的TG浓度,与TG掺入病毒基因组的程度密切相关。我们得出结论,TG抑制的SV40病毒DNA合成的一部分是由于对起始的影响,并推测这种影响可能是由于TG在复制起点的关键识别序列中取代了鸟嘌呤所致。我们通过构建含TG的SV40起始序列,然后测量它们在体外结合T抗原的能力来检验这一推测。必需的脱氧核苷三磷酸TdGTP是通过硫代脱氧鸟苷的化学磷酸化获得的。为了将TG选择性地置于所需区域,将一个含T抗原结合序列的质粒线性化,使这些序列位于分子的一端,然后用核酸外切酶III进行短暂消化。切除的链通过使用DNA聚合酶I的Klenow片段以及各种核苷酸混合物进行重新合成。尽管用含TdGTP代替dGTP的混合物进行重新合成受到一定阻碍,但使用这种类似物仍有可能实现完全重新合成。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验